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Abstract 
The HSPD1 gene encodes a protein known as HSP60 
or Hsp60, also commonly referred to as Cpn60. This 
protein is a molecular chaperone typically localized 
inside mitochondria where it forms a chaperoning 
machine with HSP10 (encoded by the HSPE1 gene), 
also called Cpn10, to assist protein folding inside the 
organelle. Hsp60 also occurs in the cytosol, plasma-
cell membrane, intercellular space, and blood. Its 
functions in all these extramitochondrial locations 
are poorly understood. While the canonical functions 
of Hsp60 are considered to be cytoprotective, anti-
stress and maintenance of protein homeostasis, other 
roles are currently being investigated. For example, 
Hsp60 participates in the pathogenesis of diseases in 
various ways in certain types of cancer, and chronic 
inflammatory and autoimmune pathological 
conditions. These are considered chaperonopathies 
by mistake, in which a normal chaperone (normal at 
least as far as it can be determined by current 
methods to study the structure of a molecule 
available only at extremely low concentrations and  
quantities) turns against the organism instead of 
protecting it, favouring the growth and 
dissemination of cancer cells, or the initiation-
progression of inflammation, for instance. In 
addition, Hsp60 mutations cause at least two types of 
severe genetic chaperonopathies. All this knowledge 
is expanding nowadays clearly pointing to Hsp60 as 
a potential target for chaperonotherapy by 
replacement when it is defective or by inhibition 
when it is pathogenic. 
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Identity 
Other names: HSP60, HSP65, HuCHA60, 
Chaperonin 60kDa (CPN60), GROEL, SPG13 
HGNC (Hugo): HSPD1 
Location: 2q33.1 
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Hsp60 and Hsp10 protein/gene/genomic data. 
The molecular anatomy of the human Hsp60: structural domains. Left: The anatomy of the human Hsp60: structural 
domains. The cartoon represents a three-dimensional model of the human Hsp60 monomer showing its three structural domains: 
apical in green, intermediate in yellow and equatorial in red. Right: This picture presents the ATP and Mg+/K+ binding sites on 
Hsp60. Particularly it shows two highly conserved sequences: 52-DGVTVAKEI-60 (orange-brown), and 85-AGDGTTTATVL-95 
(magenta) corresponding to the binding sites for Mg+/K+ (green and yellow spheres, respectively) and ATP/ADP (red). Source: 
Cappello et al., Expert Opin Ther Targets. 2014 ; 18 (2) : 185-208. PMID 24286280. 
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DNA/RNA 
Description 
The human HSP60 gene (HSPD1) contains 12 exons 
and 11 introns and was predicted to span over 
approximately 13 kb of the genomic DNA. The first 
exon is non-coding region (Hansen et al., 2003; 
Mukherjee et al., 2010). 
Transcription 
Two transcript variants encoding the same protein 
have been identified for HSPD1 
http://www.ncbi.nlm.nih.gov/gene/3329; Mukherjee 
et al., 2010). 
Pseudogene 
Twelve pseudogenes located on chromosome 3, 4, 5, 
6, 8 and 12 have been associated with HSP60 
(Mukherjee et al., 2010). 
Protein 
Description 
The HSP60 consists of 573 amino acids 
corresponding to a molecular weight of 61.05 kDa 
(Mukherjee et al., 2010). The HSP60 protein are 
abundant proteins of eubacteria genomes and 
mitochondria in eukaryotes, and also occurs in other 
locations, such as the cellular cytosol, plasma-cell 
membrane, and extracellular space (including blood) 
in eukaryotic organisms. 
HSP60 belongs to the chaperone subgroup called 
chaperonins, of which two varieties are known: 
chaperonins of Group I and chaperonins of Group II. 
The former include the human HSP60 typically 
present in the mitochondria (but also occurring in 
other locations as described above) and the bacterial 
GroEL. Chaperonins of Group II include the 
archaeal thermosome subunits and the cytosolic 
chaperonin CCT (Chaperonin-containing TCP-1). 
The human HSP60 and the bacterial GroEL form 
oligomers: seven monomers associate to form a ring 
and two rings associate end to end to build a large 
chaperoning machine of fourteen subunits, all 
identical. This tetradecamer is the HSP60 functional 
chaperoning complex that associates with Hsp60 and 
requires ATP and ATPase activity for the folding of 
substrates (Cappello et al., 2014). 
Expression 
HSP60 expression is virtually ubiquitous, since it 
can be found in cells of different tissues and organs, 
including immune system, epithelial tissue and other 
cells (Cappello et al., 2011a). However, sometimes 
its levels can be under the threshold of  
detectability by immunomorphology or 
immunoblotting.  
It can also be found in the blood (Shamaei-Tousi et 
al., 2007). 
Localisation 
HSP60 subcellular localization is mainly in the 
mitochondria, but it also occurs in extra-
mitochondrial sites such as the cytosol, cell surface, 
peroxisomes, and the endoplasmic reticulum (Soltys 
and Gupta, 1996; Soltys and Gupta, 1999; Gupta et 
al., 2008).  
Levels of extramitochondrial localization increase 
during inflammatory states (Rodolico et al., 2010; 
Tomasello et al., 2011; Cappello et al., 2011b) and 
tumorigenesis (Cappello et al., 2008; Cappello et al., 
2011c; Campanella et al., 2012; Rappa et al., 2012). 
Function 
Assisting mitochondrial protein folding, unfolding, 
and degradation (Bukau and Horwich, 1998; Fink, 
1999; Slavotinek and Biesecker, 2001; Thirumalai 
and Lorimer, 2001; Corrao et al., 2010).  
HSP60 also have anti-apoptosis and pro-apoptosis 
roles in different pathophysiologic conditions such 
as heart failure (Knowlton et al., 1998; Kirchhoff et 
al., 2002; Gupta and Knowlton, 2005; Lin et al, 
2007; Kim et al., 2009) and cancer (Chandra et al., 
2007; Campanella et al., 2008). 
Homology 
Up to now more than 150 homologues of HSP60 
sequences with pair-wise similarity extending from 
40-100% at the amino acid level. Among these
homologues one can mention those from rat rat
(Rattus norvegicus), pufferfish (Fugu rubripes),
zebrafish (Danio rerio), the nematode
Caenorhabditis elegans, mouse (Mus musculus), and
Chlamydia trachomatis (Gupta, 1995). Moreover,
Hsp60 presents a high structural homology with
other human proteins, that may act as autoantigen,
such as acetylcholine receptor, thyroglobulin, etc.
(Jones et al., 1993).
The high homology between Hsp60 of several
bacterial species and the human protein led to
postulate its involvement in molecular mimicry
phenomena with pathogenic implications
(Campanella et al., 2009; Cappello et al., 2009).
Moreover, the high homology between human and
bacterial Hsp60 and other human autoantigens led to
postulate its role in the autoimmune manifestations
of some autoimmune diseases, such as myasthenia
gravis (Cappello et al., 2010; Marino Gammazza et
al., 2012) and Hashimoto's thyroiditis (Marino
Gammazza et al., 2014).
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The human hsp60 genes and pseudogenes: genomic data. Source: Mukherjee et al. BMC Evolutionary Biology 2010 10:64. 
PMID 20193073 
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 Hsp60 presence and localization in normal tissues. Top: Normal human bronchial mucosa. Ciliated cells present Hsp60 
positivity by immunohistochemistry (IHC) in the cytosol (red spots, see arrow for example). Bottom: Normal human colonic 
mucosa. Intestinal cells do not show any positivity for Hsp60 at IHC, since the protein is under the threshold of detectability. 
Modified from: Cappello et al., Methods Mol Biol. 2011 ; 787 : 245-254. PMID 21898240 
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 Hsp60 localization localization in pathologic tissues. Top: Epithelial cell of inflamed colonic mucosa (patient with ulcerative 
colitis) showing Hsp60 positivity (immunogold) in cytosol (arrows). Modfied from Tomasello et al., 2011). Bottom: Pulmonary 
mucoepidermoid carcinoma cell (H292) showing Hsp60 positivity (immunogold) in cytosol and at plasma-cell membrane level 
(arrows). Inset: a classical mitochondrial positivity for Hsp60.Modified from Campanella et al., PLoS One. 2012 ; 7 (7) : e42008. 
PMID 22848686 
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Hsp60 function. Hsp60 works in cooperation with Hsp10, its co-chaperonin, to assist protein folding of unfolded mitochondrial 
proteins by an ATP dependent mechanism. Modified from www.pdbj.org. 
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Mutations 
Germinal 
Not known in Homo sapiens. 
Somatic 
Hereditary spastic paraplegia (SPG13) is associated 
with a mutation in the HSP60 gene: the amino acid 
72 Valine is changed to Isoleucine (Hansen et al., 
2002).  
MitCHAP-60 disease is associated with a mutation 
in the HSP60 gene: The amino acid 29 Aspartic acid 
is changed to Glycine (Magen et al., 2008).  
General note:   
HSP60 expression (mRNA) and levels (protein) 
were elevated, decreased or without changes in a 
number of cancers studied by independent groups 
with various techniques.  
For a review on this topic see: Czarnecka et al., 2006; 
Cappello et al., 2008; Rappa et al., 2012; Macario et 
al., 2013).  
Moreover, cancer cells, but not the normal 
counterparts release HSP60 via exosomes 
(Merendino et al., 2010; Campanella et al., 2012). 
Further studies on this topic are currently under way 
to better understand why Hsp60 levels change during 
carcinogenesis and what is the role of this protein in 
cancer progression 
Epigenetics 




First clinical trials using HSP60 (peptide 277) has 
been tested in type-2 diabetes. 
Disease 
HSP60 has been implicated in T cell activation and 
cause inflammatory reaction. It has been involved in 
the pathogenesis of a number of autoimmune 
diseases and inflammatory conditions such as type-1 
diabetes, juvenile chronic arthritis, atherosclerosis, 
Crohn disease, rheumatoid arthritis, systemic lupus 
erythematosus, Sjogren syndrome, Hashimoto 
thyroiditis, and myasthenia gravis (Campanella et 
al., 2009; Cappello et al., 2009; Cappello et al., 2010; 
Marino Gammazza et al., 2012; Marino Gammazza 
et al., 2014). 
Colon cancer 
Note 
For a review on Hsp60 in colon cancer, see Cappello 
et al., 2011c. 
Disease 
Hsp60 expression and levels were increased in colon 
cancer of various grades and stages compared to 
controls (Cappello et al., 2005a). This has been 
confirmed by other independent groups (Mori et al., 
2005; He et al., 2007). 
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Prognosis 
Hsp60 has been described as a potential serum 
marker for colorectal cancer (Hamelin et al., 2011). 
Oncogenesis 
Hsp60 levels increase gradually through the 
carcinogenic steps (i.e., normal-to-dysplasia-to-
carcinoma sequence) and Hsp60 is a good marker to 




The four major histological types of carcinoma of the 
lung are: squamous cell carcinoma (SCC), 
adenocarcinoma (AD), small cell carcinoma 
(SCLC), and large cell carcinoma (LCC). In some 
cases there can be a combination of histological 
patterns (Husain and Kumar, 2005). 
Disease 
Hsp60 levels were decreased in adenocarcinoma and 
adenosquamous carcinoma compared to controls 
(Cappello et al., 2005b; Cappello et al., 2006a). 
However, this has not been confirmed by another 
independent group (Xu et al., 2011) that in a series 
of lung adenocarcinomas found increased levels of 
Hsp60 compared to controls. The authors postulated 
that the possible reason to explain this contrasting 
data may be two: different TNM stages and different 
part of the tumor biopsied (e.g., central versus 
periphery). 
Prognosis 
Hsp60 levels were significantly correlated with 
TNM stage of the tumor and Eastern Cooperative 
Oncology Group performance status (Xu et al., 
2011). Multivariate statistical analysis showed that 
patient age, pathological T stage, N stage, and Hsp60 
expression were independent prognostic indicators 
with regard to disease-free survival (Xu et al., 2011). 
Oncogenesis 
Hsp60 levels decrease gradually through 
carcinogenetic steps of lung (i.e., normal-to-
dysplasia-to-carcinoma sequence) (Cappello et al., 
2005b; Cappello et al., 2006a). 
Prostate cancer 
Note 
Prostate cancer is preceded by the so called 'prostate 
intraneoplastic lesion' or PIN, a dysplastic 
(pretumoral) lesion.  
Prostatic hyperplasia is not considered a 
preneoplastic condition (Bostwick and Chen, 2012). 
Gleason score is an index of malignancy: the higher 
it is, the worse is the prognosis (Egevad et al., 2012). 
Prostate specific antigen (PSA) is a serum marker 
used for prostate cancer diagnosis and follow-up 
(Loeb et al., 2014). 
Disease 
Many studies have shown that Hsp60 levels are 
increased in prostate cancer, using 
immunohistochemistry (Cornford et al., 2000; 
Cappello et al., 2003b; Johansson et al., 2006), and 
proteomics (Skyortsov et al., 2011). HSP60 was 
significantly increased in both early and advanced 
prostate cancers when compared with non-neoplastic 
prostatic epithelium (Cornford et al., 2000). In non-
malignant prostate, HSP60-staining is localized in 
the glandular compartment, particularly basal 
epithelial cells. In prostate cancer, most epithelial 
cells showed moderate to strong staining without 
apparent correlation between staining intensity and 
Gleason grade (Johansson et al., 2006). 
Prognosis 
Recurrence-free survival in patients with strong 
HSP60 staining was shorter than in those with weak 
levels (Glaessgen et al., 2008). In another study, the 
levels of HSP60 were significantly increased in 
tumors with high Gleason score. HSP60 expression 
was also significantly associated with initial serum 
PSA levels and with the presence of lymph node 
metastasis (Castilla et al., 2010). 
Oncogenesis 
HSP60 levels increase gradually through 
carcinogenic steps (from PIN to carcinoma) of 
prostate (Cappello et al., 2003b). 
Exocervical cancer 
Note 
Exocervical cancer is preceded by the so called 
'squamous intraepithelial lesion' or SIL, a dysplastic 
(pretumoral) lesion (Garrett and McCann, 2013). 
SIL, as well as exocervical cancer, have been related 
to infection by Human Papilloma Virus (HPV) 
(Garrett and McCann, 2013). 
Disease 
Hsp60 levels are increased in exocervical cancer, as 
shown by immunohistochemistry (Cappello et al., 
2002-2003; Castle et al., 2005). 
Oncogenesis 
HSP60 levels increase gradually through 
carcinogenic steps (from SIL to carcinoma) of 
exocervix (Cappello et al., 2002-2003). 
Vesical cancer 
Disease 
HSP60 levels are decreased in vesical cancers such 
as bladder carcinoma (Lebret et al., 2003; Cappello 
et al., 2006b). 
Prognosis 
HSP60 is considered a useful marker for patients 
with superficial bladder carcinoma for predicting 
disease progression: lower levels correlate with 
worse outcome of local treatments. Particularly, 
HSP60 levels are considered useful prognostic 
marker to identify patients for whom local treatment 
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would be insufficient (Lebret et al., 2003). Hsp60 
levels may predict response to neoadjuvant 
chemoradiotherapy in invasive or high-risk 
superficial bladder cancer (Urushibara et al., 2007). 
To be noted 
HSP60 may participate in the process of 
carcinogenesis, representing cases of 
chaperonopathies by mistake or collaborationism in 
which a normal chaperone (at least considering the 
methods available nowadays to characterize 
intracellular molecules, or extracellular molecules at 
very low concentrations) contributes to cancer 
development (Macario et al., 2013). 
HSP60 may participate also in the process of chronic 
inflammation (Cappello et al., 2011b) and 
autoimmune diseases (Cappello et al., 2009), also by 
molecular mimicry phenomena. For example, 
atherosclerosis has been postulated to be an 
autoimmune disease due to an immune reaction 
against heat-shock protein 60 (Wick et al., 2014). 
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